000 01629 a2200421 4500
005 20250518011646.0
264 0 _c20190308
008 201903s 0 0 eng d
022 _a1521-0669
024 7 _a10.1080/08880018.2018.1538277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVyas, Chintan
245 0 0 _aExperience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.
_h[electronic resource]
260 _bPediatric hematology and oncology
_c
300 _a331-340 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aAsparaginase
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aDaunorubicin
_xadministration & dosage
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Monitoring
650 0 4 _aDrugs, Generic
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aSurvival Rate
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aJain, Sandeep
700 1 _aKapoor, Gauri
700 1 _aMehta, Anurag
700 1 _aTakkar Chugh, Parul
773 0 _tPediatric hematology and oncology
_gvol. 35
_gno. 5-6
_gp. 331-340
856 4 0 _uhttps://doi.org/10.1080/08880018.2018.1538277
_zAvailable from publisher's website
999 _c29102811
_d29102811